Apheresis Equipment Market Booms: 8% CAGR to Drive US$ 4.95 Bn Growth by 2031

The Apheresis Equipment Market is experiencing a period of sustained growth as healthcare systems increasingly adopt advanced blood component separation technologies for both therapeutic and donation purposes. Apheresis, which allows for the selective removal of specific blood components while returning the remaining elements to the patient or donor, has become an essential tool in modern medicine. Its expanding role across hematology, neurology, renal diseases, and other clinical applications is driving strong market momentum worldwide.

According to industry estimates, the Apheresis Equipment Market is expected to register a compound annual growth rate (CAGR) of 8.00% from 2025 to 2031. The market size, valued at US$ 2.89 billion in 2024, is projected to reach US$ 4.95 billion by 2031, reflecting growing clinical acceptance, technological advancements, and increasing prevalence of chronic and life-threatening diseases.

Understanding the Importance of Apheresis in Modern Healthcare

Apheresis procedures are designed to target specific components of blood, such as plasma, platelets, leukocytes, erythrocytes, or low-density lipoproteins (LDL). Unlike traditional blood transfusion methods, apheresis offers higher precision, improved safety, and enhanced therapeutic outcomes. This makes it particularly valuable in conditions where selective removal of harmful or excess components can significantly improve patient health.

The rising burden of autoimmune disorders, hematological malignancies, neurological diseases, and renal conditions has made apheresis an indispensable part of treatment protocols. As a result, hospitals, blood banks, and specialty clinics are increasingly investing in advanced apheresis equipment.

Market Segmentation by Product

From a product perspective, the apheresis equipment market is segmented into apheresis machines and disposable apheresis kits.

Apheresis machines represent the core of the market, integrating sophisticated control systems, sensors, and software that enable real-time monitoring of blood flow, component separation, and patient safety. Continuous innovation has led to more compact, user-friendly, and automated systems, improving procedural efficiency and reducing operator dependency.

Disposable apheresis kits are gaining significant traction due to rising concerns over infection control and cross-contamination. These single-use kits ensure higher safety standards, streamline workflow, and align with stringent regulatory guidelines. The growing adoption of disposable kits is expected to be a key contributor to overall market growth during the forecast period.

Technology Landscape: Centrifugation and Membrane Separation

Technological advancements play a crucial role in shaping the apheresis equipment market. Two primary technologies dominate the landscape: centrifugation and membrane separation.

Centrifugation technology remains the most widely used method due to its reliability and versatility. It is extensively employed in procedures such as plasmapheresis, plateletpheresis, leukapheresis, and erythrocytapheresis. Centrifugation systems are particularly popular in blood donation centers and hospitals because of their efficiency in separating blood components based on density.

On the other hand, membrane separation technology is witnessing growing adoption, especially in therapeutic procedures that require high selectivity. This technology is increasingly used in LDL-apheresis and certain renal disease treatments, where precise filtration of specific molecules is critical. Continuous improvements in membrane materials and design are enhancing performance while minimizing damage to blood cells.

Procedure-Based Market Dynamics

The versatility of apheresis is reflected in its wide range of clinical procedures, including:

Plasmapheresis
Plateletpheresis
Leukapheresis
Erythrocytapheresis
LDL-Apheresis
Photopheresis

Among these, plasmapheresis holds a dominant market share due to its extensive use in autoimmune and neurological disorders. Plateletpheresis and leukapheresis are widely utilized in hematological conditions and oncology settings, while LDL-apheresis is gaining prominence as a life-saving therapy for patients with severe hypercholesterolemia unresponsive to conventional treatments.

Photopheresis, an immunomodulatory therapy, is also emerging as an important procedure for managing graft-versus-host disease and certain autoimmune conditions.

Therapeutic Areas Driving Market Growth

By therapeutic area, the apheresis equipment market is segmented into hematology, renal diseases, neurology, and other applications.

The hematology segment accounts for the largest share of the market, driven by increasing cases of leukemia, thrombocytosis, sickle cell disease, and other blood disorders. Apheresis procedures allow clinicians to manage these conditions more effectively by selectively removing pathological components.

The neurology segment is expanding rapidly, supported by growing evidence for the effectiveness of plasmapheresis in treating neurological disorders such as multiple sclerosis and Guillain-Barré syndrome. Meanwhile, renal disease applications are benefiting from advancements in membrane separation technologies that support toxin removal and immune regulation.

Key Companies and Competitive Landscape

The global apheresis equipment market is highly competitive, with leading players focusing on innovation, strategic partnerships, and geographic expansion. Key companies operating in this space include:

Fresenius Medical Care AG & Co. KGaA
Terumo Corporation
B. Braun Melsungen AG
Asahi Kasei Corporation
Haemonetics Corporation
Medica SPA
HemaCare Corporation
Kaneka Medix Corporation
Kawasumi Laboratories, Inc.

These companies are investing heavily in research and development to introduce next-generation apheresis systems that offer enhanced safety, automation, and efficiency. Their strong global presence and diversified product portfolios play a critical role in shaping market trends.

Future Outlook

Looking ahead, the Apheresis Equipment Market is poised for robust growth as precision medicine, rising chronic disease prevalence, and technological advancements continue to drive demand. The market’s projected expansion from US$ 2.89 billion in 2024 to US$ 4.95 billion by 2031, at a CAGR of 8.00%, underscores its growing importance in modern healthcare.

As awareness increases and access to advanced therapies improves, apheresis equipment will continue to play a pivotal role in improving patient outcomes across multiple therapeutic areas.

Related Reports

Leukapheresis Market Outlook and Strategic Insights by 2028
Blood Transfusion Devices Market Growth, Size, Share, Trends, Key Players Analysis, and Forecast till 2031
Plasmapheresis Machines Market Growth, Trends, and Forecast by 2034

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.

Contact Us:

If you have any queries about this report or if you would like further information, please get in touch with us:

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876